Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
40mg
|
|||
Strength
80mg
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Retevmo (Selpercatinib) is a medication used to treat specific types of advanced cancer by targeting alterations in the RET gene. It works by blocking the activity of the RET proteins, which can drive cancer growth when mutated or fused. Classified as a kinase inhibitor due to its ability to block these proteins, Retevmo is mainly used in treating non-small cell lung cancer (NSCLC) and thyroid cancer when these cancers are advanced or metastatic and test positive for RET gene changes. Patients take Retevmo orally, typically as part of a broader cancer treatment regimen.
Retevmo is taken in capsule form. Patients typically take it twice a day, with or without food. It's crucial to swallow capsules whole, not to crush, chew, or open them. The standard dosage depends on various factors, including the patient's weight and overall health, and should follow the physician's guidance closely. Generally, adults start with 160 mg twice daily for individuals who weigh 50 kg or more, and 120 mg twice daily for those under 50 kg.
Retevmo contains the active ingredient Selpercatinib. Inactive ingredients may include microcrystalline cellulose and colloidal silicon dioxide.
No contraindications are listed on the drug label. However, it should be avoided in people with a known allergy to Selpercatinib or any of the ingredients within the drug formulation.
Patients taking Retevmo may experience edema (swelling of arms, legs, hands, and feet), along with stomach pain, diarrhea, constipation, fatigue, rash, dry mouth, nausea, high blood pressure, and headaches. Retevmo side effects are typically the body's initial reaction to the medication.
Retevmo carries the risk of significant health concerns, including liver issues marked by jaundice, dark urine, and stomach pain; lung problems characterized by shortness of breath and cough; severe high blood pressure; changes in heart rhythm; and serious bleeding events. It can also cause allergic reactions, tumor lysis syndrome leading to kidney failure and abnormal heart rhythms, problems with wound healing, and hypothyroidism. Furthermore, Retevmo may impact fertility in both genders. Patients should have regular health check-ups to monitor for these conditions and report any severe side effects to their healthcare provider immediately.